BI 167107
CAS No. 1202235-68-4
BI 167107 ( BI167107 )
产品货号. M10729 CAS No. 1202235-68-4
BI 167107 is a highly potent agonist of the β2 adrenergic receptor (β2AR) and β1AR (IC50=3.2 nM) and shows some activity as α1A antagonist (IC50 = 32 nM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2406 | 有现货 |
|
50MG | ¥11016 | 有现货 |
|
100MG | ¥15066 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BI 167107
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BI 167107 is a highly potent agonist of the β2 adrenergic receptor (β2AR) and β1AR (IC50=3.2 nM) and shows some activity as α1A antagonist (IC50 = 32 nM).
-
产品描述BI 167107 is a highly potent agonist of the β2 adrenergic receptor (β2AR) and β1AR (IC50=3.2 nM) and shows some activity as α1A antagonist (IC50 = 32 nM); due to its high potency and slow dissociation from the target BI-167107 was subsequently used to support crystallization of active state β2AR and β2AR-G-protein complexes.
-
同义词BI167107
-
通路Angiogenesis
-
靶点Adrenergic Receptor
-
受体Adrenergic Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number1202235-68-4
-
分子量370.45
-
分子式C21H26N2O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(N1)COC2=C1C(O)=CC=C2C(CNC(C)(C)CC3=C(C)C=CC=C3)O
-
化学全称5-hydroxy-8-(1-hydroxy-2-((2-methyl-1-(o-tolyl)propan-2-yl)amino)ethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Weiss DR, et al. ACS Chem Biol. 2013 May 17;8(5):1018-26.
2. Ring AM, et al. Nature. 2013 Oct 24;502(7472):575-579.
3. Manglik A, et al. Cell. 2015 May 21;161(5):1101-1111.
4. Kahsai AW, et al. Nat Chem Biol. 2016 Sep;12(9):709-16.
2. Ring AM, et al. Nature. 2013 Oct 24;502(7472):575-579.
3. Manglik A, et al. Cell. 2015 May 21;161(5):1101-1111.
4. Kahsai AW, et al. Nat Chem Biol. 2016 Sep;12(9):709-16.
产品手册
关联产品
-
orcinol
Orcinol is an active biochemical.
-
Citrulline
Citrulline is an α-amino acid.
-
Dibenamine hydrochlo...
Dibenamine hydrochloride is a competitive and irreversible blocking agent of the β-adrenergic receptor.